This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
September 2023 saw a wave of new pharmaceuticalmanufacturing facility expansions and launches across Europe. Importantly, each site features advanced technologies to support development and manufacture of these therapeutics. Materials and financing costs are high and squeezing manufacturers and their customers alike.
This step is important as these countries are key markets for pharmaceuticalsmanufacturing. GSK propels its progress to Net Zero Renewable energy in the pharma supply chain The SMI Health Systems Task Force is a public-private partnership launched at COP26.
The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceuticalmanufacturing and quality control. Additionally the pharmaceutical AI market is projected to reach $11.8
A pull strategy is needed with financial incentives to repair the broken market for antibiotics and make it worthwhile for the pharma industry to bring promising drugs to market. Pew Internet reminds us all that, above all, the pharma industry is a business. The pharma industry is warning of the consequences of inaction. “If
The manufacturing site will be completed in three phases and will produce anti-bacterial medicines and anti-malarial drugs. Fosun Pharma chairman Wu Yifang stated: “We are glad to be supported by IFC to localise pharmaceuticalmanufacturing and distribution in Africa.
It’s critical to keep your workplace equipment clean and calibrated—especially in the realm of pharmaceuticalmanufacturing. Now, Dr. | It’s critical to keep your workplace equipment clean and calibrated—especially in the realm of pharmaceuticalmanufacturing.
The inventory position of 28 major pharmaceuticalmanufacturers in 2022 has been revealed in an annual report. Analysis explored the impact of macro-trends on inventory management from corporate reports of Big Pharma companies including Merck, AstraZeneca and Pfizer.
A study of the causes of warning letters issued by the US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) and Center for Devices and Radiological Health (CDRH) between 2010 and 2020 revealed that poor current good manufacturing practice (cGMP) compliance and misbranding were the most common citations.
The International Federation of PharmaceuticalManufacturers and Associations (IFPMA) has unveiled the upcoming lineup for its CEO leadership team over the next two years. A new triumvirate of biopharma bigwigs is in line to reign over one of the industry’s top trade groups. |
Novo Nordisk has announced plans to invest over 42 billion Danish kroner (nearly £5 billion) starting in 2023, to expand its manufacturing facilities in Kalundborg, Denmark. According to the pharma company , the financing will add to global capacity: from manufacturing of active pharmaceutical ingredients (API) through to packaging.
QUICK READ: Pharma supply chain issues are a concern for us all but especially patients. Hedley Rees has written a book on pharma supply chains that is eye-opening and downright scary. Can patients really be confident in pharma supply chains? Why would a pharma company take risks like these? Patients should be scared.
NEW, FLEXIBLE, data-driven manufacturing models are emerging to address the pharmaceutical industry’s need for greater operational efficiency. The post Innovating pharma at the edge appeared first on European Pharmaceutical Review.
The pharmaceutical industry is becoming increasingly conscious of emissions and the importance of sustainable manufacturing. Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available.
International companies investing in the emerging market of Brazilian pharmaceuticalmanufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.
There has been a steady stream of developments in the vaccine manufacturing space throughout 2023. A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre.
A new global Minimized Risk of Antimicrobial Resistance (AMR) certification has been launched to promote and demonstrate responsible antibiotic manufacturing in the global pharmaceutical supply chain. BSI, a UK standards body, developed the new certification to the Antibiotic Manufacturing Standard published in June 2022.
Aurobindo Pharma-Openings for Freshers in Quality Control-Apply Now. Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Freshers (Quality Control) -Apply Now @ Aurobindo Pharma. Job Description. Greetings from Aurobindo !!! Link: [link].
Aurobindo Pharma-Walk-In Interviews for Freshers in Production/ Packing On 4th Jan’ 2023. Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!! Job Description. Experience: Freshers.
M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.
The pharmaceutical industry must improve its environmental footprint by investing in technology and expertise, as well as through better design of new drugs early in their development, according to a GlobalData survey of the pharmaceutical industry.
In the interview, conducted at CPHI Barcelona, Krishna Venkatesh, Global Head, Sterile Manufacturing Operations at Dr Reddy’s Laboratories explores industry’s growing focus on achieving end-to-end connectivity, as well as the potential of automation and track and trace solutions. What trends are you seeing in the pharma space?
Aurobindo Pharma-Walk-In Interviews for QC/ QA/ Production Departments On 17th Sept’ 2022. Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Job Description. Greetings from Aurobindo !!! Experience: 1 to 5 years.
Aurobindo Pharma-Walk-In Interviews for Quality Control/ Production On 7th Jan’ 2023. Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!! Job Description. Experience: 2 to 6 years.
APL Health Care (Aurobindo )-Openings for Manufacturing / Packing Department- Apply Now Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo !!!
Aurobindo Pharma-Hiring M.Pharm/ B.Pharm/ B.Sc/ ITI/ Diploma for Packing Dept. Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8
Aurobindo Pharma-Walk-In Interviews for Packing Department On 4th Feb’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!! TA/ Executive/ Sr.
Aurobindo Pharma-Openings for Quality Control/ Production/ Quality Assurance -Apply Now Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!!
Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 28th Jan’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!!
Aurobindo Pharma-Walk-In Interviews for Quality Control On 3rd Feb’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!!
Aurobindo Pharma-Walk-In Interviews for Production/ Quality Control/ Packing On 5th Mar’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!!
Supply chain shortages have dominated headlines for several months, and the pharma industry has been no exception. The pandemic effectively shut down supply chain paths overnight, and as a result, pharmaceuticalmanufacturers have faced delays and bottlenecks, which have caused drug shortages in healthcare systems.
Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 7th Jan’ 2023. Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!! Job Description.
It’s imperative that pharma businesses understand what their potential customers are searching for when they are typing into search fields. But pharma has had a tendency to shy away from search engine optimization (SEO) strategy; however, for those who do engage with SEO marketing, the rewards can be high.
This report delves into the latest developments in sustainability impacting the pharmaceutical sector today. Inside, articles explore current key topics including regulation, manufacturing, green chemistry, digitalisation and clinical trials. Interested?
Download this report to discover key environmental monitoring trends impacting pharmaceuticalmanufacturers today, including the latest requirements for contamination control, the shift towards rapid methods and the latest regulations on bacterial endotoxin testing. Interested? Register your details now to download for free today!
Aurobindo Pharma-Requirement for Production/ Quality Control/ Quality Assurance Dept. Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 We are looking for Production/ Quality Control/ Quality Assurance @ Aurobindo Pharma.
Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology. It also has the potential to reduce the high carbon footprint associated with manufacturing.
Although the driving factors of the shortage are complex, the bottom line is that drug manufacturers, particularly those that produce generic drugs, can’t afford to stockpile raw materials and products to prepare for shortages due to financial, storage capability, and product expiry limitations.
The pandemic had a huge impact on the way population health decision-makers (PHDMs) navigate our industry, and now that it’s clear many of these shifts are here to stay, pharmaceuticalmanufacturers need to adjust accordingly. PHDMs know contracting alone won’t be enough to solve these challenges.
Furthermore, by simulating real-life scenarios, AR offers the chance for staff in the pharma industry to practice complex operations without the associated risks. For instance, in pharmaceuticalmanufacturing, mistakes in training can lead to contamination or waste, which can cause businesses unnecessary headaches.
The pharmaceutical firm is investing greatly in its existing infrastructure to facilitate the shift to renewable gas and support a transition to 100 percent renewable energy. This includes its Macclesfield campus, the UK’s largest pharmamanufacturing site.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content